Clinical Outcomes and Associated Factors of Antibody-mediated Rejection without Detectable Donor-specific Antibodies in Kidney Transplantation
American Journal of Nephrology · 06.11.2026
DOI: 10.1159/ajn/ablag034 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Nephrology, online erschienen am 06.11.2026. Verfasst von Byounghwi Ko und 17 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Antibody-mediated rejection (ABMR) remains a leading cause of late kidney allograft loss. Recently, microvascular inflammation in kidney biopsy without detectable donor-specific antibodies (DSA)—termed DSA-negative ABMR (DSAneg ABMR)—is increasingly recognized.
Methods
We used the nationwide Korean Transplantation Registry (KOTRY) to compare outcomes among biopsy-proven DSA-positive ABMR (DSApos ABMR), DSAneg ABMR, and T-cell–mediated rejection (TCMR). From 10,391 kidney transplant recipients, 740 patients met inclusion criteria (DSAneg ABMR 90; DSApos ABMR 124; TCMR 526). The primary outcome was kidney graft failure. Cause-specific competing risk models were applied. To elucidate mechanisms of DSAneg ABMR, we integrated KOTRY with an in-depth single-center data, enrolling 56 patients for serologic, genetic, and pathologic investigations using stored biospecimens.
Results
Over 2,610.1 person-years (median follow-up 3.10 years), the primary outcome occurred in 93 (12.6%) patients (14 in DSAneg ABMR, 15 in DSApos ABMR, and 64 in TCMR; incidence 3.56/100 person-years). Versus DSAneg ABMR, fully adjusted hazard ratios (HRs) for the kidney graft failure were 0.78 (95% CI, 0.36–1.69; P=0.52) for DSApos ABMR and 0.64 (0.35–1.18; P=0.15) for TCMR. In the etiologic cohort (n=56), frequent findings included MIC-A and MIC-B gene mismatches (16/19 [84.2%] and 15/19 [78.9%]), SIRPα B-to-A incompatibility (7/19 [36.8%]), kidney-relevant autoantibodies (21/52 [40.4%]), and missing self for NK cells (9/18 [50.0%]). Late-appearing DSAs, MIC-A mismatch, and missing self were associated with worse graft outcomes. While overall Banff scores were comparable between the ABMR groups, the DSAneg group exhibited higher tubulitis and lower microvascular inflammation scores.
Conclusion
Both DSApos ABMR and DSAneg ABMR confer higher risks of adverse outcomes than TCMR in a Korean national cohort. DSAneg ABMR is etiologically heterogeneous with different prognosis. Further prospective studies with systematic biospecimen collection are warranted.
Autor:innen und Institutionen
ORCID-Profile: Younhee Park, Young Jin Kim, Hyung Woo Kim, Jin Sug Kim, Jaeseok Yang
Zitieren
APA
Ko, B., Park, Y., Kim, S. M., Kim, Y. J., Koh, H. B., Kim, H. W., Piao, H., Lon, V., Jung, M., Kim, H. J., Lee, J., Huh, K. H., Seok Kim, B., Kim, M. S., Kim, J. S., Han, S., Kwon, Y. J., & Yang, J. (2026). Clinical Outcomes and Associated Factors of Antibody-mediated Rejection without Detectable Donor-specific Antibodies in Kidney Transplantation. American Journal of Nephrology. https://doi.org/10.1159/ajn/ablag034
Vancouver
Ko B, Park Y, Kim SM, Kim YJ, Koh HB, Kim HW, et al. Clinical Outcomes and Associated Factors of Antibody-mediated Rejection without Detectable Donor-specific Antibodies in Kidney Transplantation. American Journal of Nephrology. 2026. doi:10.1159/ajn/ablag034
BibTeX
@article{Ko2026,
author = {Ko, Byounghwi and Park, Younhee and Kim, Sung Min and Kim, Young Jin and Koh, Hee Byung and Kim, Hyung Woo and Piao, Honglin and Lon, Virithy and Jung, Minsun and Kim, Hyun Jeong and Lee, Juhan and Huh, Kyu Ha and Seok Kim, Beom and Kim, Myoung Soo and Kim, Jin Sug and Han, Seungyeup and Kwon, Young Joo and Yang, Jaeseok},
title = {Clinical Outcomes and Associated Factors of Antibody-mediated Rejection without Detectable Donor-specific Antibodies in Kidney Transplantation},
journal = {American Journal of Nephrology},
year = {2026},
doi = {10.1159/ajn/ablag034}
}
EUVIMED